Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Progressive | PGR | Oct 11, 2024 | 254.09 | +0.92 |
Progyny | PGNY | Oct 11, 2024 | 16.10 | -2.13 |
Project Energy Reimagined Acquisition Unit | PEGRU | Oct 11, 2024 | 11.10 | 0.00 |
ProKidney | PROK | Oct 11, 2024 | 1.83 | +7.65 |
Prologis | PLD | Oct 11, 2024 | 120.24 | +1.66 |
ProMIS Neurosciences | PMN | Oct 11, 2024 | 1.02 | +0.99 |
PropertyGuru | PGRU | Oct 11, 2024 | 6.62 | +0.15 |
ProPetro | PUMP | Oct 11, 2024 | 8.38 | +1.45 |
ProPhase Labs | PRPH | Oct 11, 2024 | 2.41 | +8.07 |
ProQR Therapeutics | PRQR | Oct 11, 2024 | 1.85 | -1.60 |
PROS | PRO | Oct 11, 2024 | 18.65 | +0.97 |
ProShares Bitcoin Strategy ETF | BITO | Oct 11, 2024 | 17.98 | +5.83 |
Proshares Ultra FTSE Europe | UPV | Oct 11, 2024 | 66.08 | +1.20 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Oct 11, 2024 | 67.44 | +3.74 |
Proshares Ultrashort FTSE Europe | EPV | Oct 11, 2024 | 7.04 | -1.19 |
Prospect Capital | PSEC | Oct 11, 2024 | 5.08 | -1.36 |
Prospect Capital A Pref | PSEC-A | Oct 11, 2024 | 20.85 | +4.77 |
Prosperity Bancshares | PB | Oct 11, 2024 | 72.63 | +2.50 |
Protagenic Therapeutics | PTIX | Oct 11, 2024 | 0.51 | -12.64 |
Protagonist Therapeutics | PTGX | Oct 11, 2024 | 45.08 | +3.42 |
Protalix Bio Therapeutics | PLX | Oct 11, 2024 | 1.08 | +8.00 |
Protara Therapeutics | TARA | Oct 11, 2024 | 1.68 | +3.70 |
Prothena | PRTA | Oct 11, 2024 | 17.22 | +2.62 |
Proto Labs | PRLB | Oct 11, 2024 | 28.44 | +1.83 |
Provident Bancorp | PVBC | Oct 11, 2024 | 10.73 | +4.48 |
Provident Financial | PROV | Oct 11, 2024 | 14.56 | +0.41 |
Provident Financial Services | PFS | Oct 11, 2024 | 18.83 | +4.09 |
Prudential ADR | PUK | Oct 11, 2024 | 17.73 | -1.23 |
Prudential Financial | PRU | Oct 11, 2024 | 123.72 | +1.66 |
Ps International Group | PSIG | Oct 11, 2024 | 0.84 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.